NMD罕见病试验失败，但借次要数据加速项目推进
NMD flunks rare disease trial but flexes secondary data to accelerate program
生命科学资讯
生物技术与制药领域的最新动态
奎斯特推出多发性骨髓瘤残留病灶血液检测
Quest launches residual disease blood test for multiple myeloma
财报电话会议纪要：龙沙集团2025年第四季度业绩未达预期，股价下跌9% - Investing.com
Earnings call transcript: Lonza misses Q4 2025 forecasts, stock drops 9% - Investing.com
Strengthening Families & Communities LLC购入4,825股赛默飞世尔科技公司股票$TMO - MarketBeat
Strengthening Families & Communities LLC Purchases 4,825 Shares of Thermo Fisher Scientific Inc. $TMO - MarketBeat
Thermo Fisher将关闭马萨诸塞州富兰克林工厂，影响超百个工作岗位——米尔福德每日新闻报
Thermo Fisher to close Franklin MA plant; more than 100 jobs affected - Milford Daily News
Mediolanum国际基金有限公司出售15,620股安捷伦科技公司$A股票 - MarketBeat
Mediolanum International Funds Ltd Sells 15,620 Shares of Agilent Technologies, Inc. $A - MarketBeat
Mirum如何通过战略并购推动罕见病护理进步
How Mirum is Advancing Rare Disease Care Through Strategic M&A
蒙纳士创新实验室与安捷伦合作，加强澳大利亚应用研究 - 亚洲生物光谱
Monash Innovation Labs and Agilent partner to strengthen applied research in Australia - BioSpectrum Asia
赛默飞世尔科技（TMO）2025年业绩超预期后股价下跌7.2%——市场反应背后的变数
Thermo Fisher Scientific (TMO) Is Down 7.2% After Stronger‑Than‑Expected 2025 Earnings Beat Expectations - What's Changed - simplywall.st
安捷伦科技公司(A)股票分析：潜在26.76%上涨空间提振投资者信心——DirectorsTalk专访
Agilent Technologies, Inc. (A) Stock Analysis: Potential 26.76% Upside Raises Investor Optimism - DirectorsTalk Interviews
德意志银行维持对龙沙集团（LZAGY）2026年2月“买入”评级 - 迈卡
Deutsche Bank Maintains Buy on Lonza Group AG (LZAGY) Feb 2026 - Meyka
沃特世公司(WAT)：看涨理论分析 - 内部人士观点
Waters Corporation (WAT): A Bull Case Theory - Insider Monkey
沃特世公司(WAT)：看涨理论分析 - Finviz
Waters Corporation (WAT): A Bull Case Theory - Finviz
诺和诺德CagriSema在3期糖尿病研究中优于司美格鲁肽。
Novo’s CagriSema tops semaglutide in ph. 3 diabetes study
Carbon Health申请破产，寻求出售或重组。
Carbon Health files for bankruptcy, seeking to sell or restructure
安捷伦将于2月25日公布2026财年第一季度财务业绩 - Business Wire
Agilent to Announce First-Quarter Fiscal Year 2026 Financial Results on Feb. 25 - Business Wire
安捷伦将于2月25日公布2026财年第一季度财务业绩 - FinancialContent
Agilent to Announce First-Quarter Fiscal Year 2026 Financial Results on Feb. 25 - FinancialContent
首批10种医保谈判药品价格已生效：老年人真的省钱了吗？
First 10 Medicare-negotiated drug prices have taken effect: Are seniors really saving money?
葛兰素史克归还Wave遗传病RNA编辑技术权利
GSK gives back rights to Wave's genetic disease RNA editor
赛默飞世尔关闭富兰克林工厂，缩减马萨诸塞州员工规模。
Thermo Fisher trims Massachusetts headcount with Franklin site closure